交易中 04-01 11:21:09 美东时间
+0.730
+2.88%
今日重点评级关注:Benchmark:维持Klaviyo"买入"评级,目标价从30美元升至33美元;富国银行:维持Cloudflare"超配"评级,目标价从265美元升至270美元
02-12 14:02
今日重点评级关注:HC Wainwright & Co.:维持内克塔治疗"买入"评级,目标价从135美元升至165美元;BTIG:维持内克塔治疗"买入"评级,目标价从118美元升至151美元
02-11 11:02
今日重点评级关注:HC Wainwright & Co.:维持NovaBridge Biosciences"买入"评级,目标价从7美元升至9美元;Truist Securities:维持Reddit"买入"评级,目标价从270美元升至275美元
02-09 14:37
The software-driven sell-off paused for a breather on Friday after eight straight sessions that had hammered the iShares Tech-Expanded Software Sector ETF (NYSE:IGV)
02-07 02:25
Wells Fargo analyst Vik Chopra maintains Envista Holdings (NYSE:NVST) with a Equal-Weight and raises the price target from $21 to $26.
02-07 00:02
华盛资讯2月6日讯,Envista Holdings公布2025财年Q4业绩,公司Q4营收7.51亿美元,同比增长15.0%,归母净利润0.33亿美元,同比增长2641.7%。
02-06 17:35
Envista Holdings预计于2月5日收盘后公布季报,分析师预期每股收益为0.32美元,营收为6.7808亿美元。
02-06 05:44
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Dental sector may steady in 2026, but full recovery remains distant, analysts say By Sriparna Roy and Padmanabhan Ananthan Feb 4 (Reuters) - Wall Street is hoping dental-product makers will offer a brighter 2026 outlook, but analysts say a full industry rebound may still be some time away. From Hen
02-05 02:32